» Articles » PMID: 8419089

T Cell Redistribution Kinetics After Secondary Infection of BALB/c Mice with Respiratory Syncytial Virus

Overview
Date 1993 Jan 1
PMID 8419089
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

BALB/c mice were infected intranasally with live respiratory syncytial virus (RSV) and reinfected 4 weeks later. At regular intervals thereafter groups of animals were killed and T cell subsets were determined in blood, spleen and bronchoalveolar lavage (BAL) with flow cytometry employing T cell subset-specific MoAbs. Total lymphocyte counts in the peripheral blood decreased 1-3 days after infection, returning to preinfection levels on day 8 (P = 0.0111). Simultaneously, a marked increase of lymphocytes was noted in the BAL, reaching a maximum at day 8 (P < 0.0001). Both CD4+ and CD8+ T cells decreased in the blood on day 1-3 (P < 0.0097 and P = 0.003 respectively), and increased in the BAL progressively towards a maximum at day 8 (P < 0.0001). In BAL, CD4+ cells increased 35-fold and CD8+ cells 27-fold during the first week after reinfection. On the other hand, in the spleen a significant decline of CD4+ and CD8+ cells was noted 1 day post-infection (P = 0.0002). It is concluded that a strong T cell redistribution response among systemic and mucosal tissues occurs after reinfection with RSV. The kinetics of this response differ both quantitatively and qualitatively from the T cell response after primary infection. The magnitude of cell traffic is more pronounced in blood, spleen and BAL than after primary infection. CD4+ T cells are more intensively distributed to the lungs than after primary infection.

Citing Articles

The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Oshansky C, Zhang W, Moore E, Tripp R Future Microbiol. 2009; 4(3):279-97.

PMID: 19327115 PMC: 2711508. DOI: 10.2217/fmb.09.1.


Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

McNamara P, Ritson P, Selby A, Hart C, Smyth R Arch Dis Child. 2003; 88(10):922-6.

PMID: 14500316 PMC: 1719332. DOI: 10.1136/adc.88.10.922.


Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV.

Waris M, Tsou C, Erdman D, Day D, Anderson L J Virol. 1997; 71(9):6935-9.

PMID: 9261421 PMC: 191977. DOI: 10.1128/JVI.71.9.6935-6939.1997.

References
1.
Pemberton R, Cannon M, Openshaw P, Ball L, Wertz G, Askonas B . Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J Gen Virol. 1987; 68 ( Pt 8):2177-82. DOI: 10.1099/0022-1317-68-8-2177. View

2.
Bangham C, Openshaw P, Ball L, King A, Wertz G, Askonas B . Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol. 1986; 137(12):3973-7. View

3.
Isaacs D, Bangham C, McMichael A . Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet. 1987; 2(8562):769-71. DOI: 10.1016/s0140-6736(87)92502-5. View

4.
Cannon M, Openshaw P, Askonas B . Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med. 1988; 168(3):1163-8. PMC: 2189034. DOI: 10.1084/jem.168.3.1163. View

5.
Nicholas J, Mitchell M, Levely M, Rubino K, Kinner J, Harn N . Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus. J Virol. 1988; 62(12):4465-73. PMC: 253555. DOI: 10.1128/JVI.62.12.4465-4473.1988. View